课题基金 / 基金详情

DEVELOPMENT OF METHODS FOR THE DIAGNOSIS OF LEISHMANIASIS AND ADVENTITIOUS AGENTS

DEVELOPMENT OF METHODS FOR THE DIAGNOSIS OF LEISHMANIASIS AND ADVENTITIOUS AGENTS
利什曼病和外来病原体诊断方法的开发
批准号:
6293688
负责人:
Hira L. Nakhasi
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Hira L. Nakhasi的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Trypanosomatid parasites of the genus Leishmania infect close to 15 million people world-wide. Diagnosis is difficult in endemic areas because of the currently avialbe detection schemes are inadequate because of lack of sensitivity, time intensiveness. Recent concern regarding possible link between the Gulfwar syndrome and Leishmaniasis has accentuated the lack of and need for better diagnostic modalities for both patients and blood products. A more reliable target for detection is the parasite's own mitochondrial DNA (kDNA)which remains constant through its life cycle and is present in thousands of copies per cell. We have characterized kDNA sequences from eight different Leishmania isolates and have used a PCR-based scheme to design detection systems for several species. This techinque can readily detect Leishmania kDNA from single cell in the presence of vast amounts of human DNA. The utility of these PCR schemes has been further shown by their ability to positively identify parasite isolates from kala-azar patients and individuals with cutaneous infections. Based on our experience with the PCR-based detection schemes, we want to expolite this techique to detect adventious agents in the parasite vaccines. Many species of Leishmania are persistently infected with double stranded RNA virus named as Leishmainavirus (LRV). The complete nucleotide sequences of two LRV isolates from both new world and old world strains have been reported. We plan to identify sequences which are conserved among the strains and develop primers which can be used in the PCR based detection assay. Using these primers we will develop PCR assay to detect the virus in wide range of isolates form different regions of the world which are available to us. We would also like to test various vaccine preprartions, obtained from WHO, to test the presence of viral sequences in them.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF MALARIA MULTIPLE ANTIGEN PEPTIDE(MAP) VACCINE
  • 批准号:
    6293691
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Hira L. Nakhasi
  • 依托单位:
    --
IMMUNOPATHOGENESIS OF RUBELLA VIRUS ASSOCIATED AUTOIMMUNE DYSFUNCTION
  • 批准号:
    6161327
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Hira L. Nakhasi
  • 依托单位:
    --
IMMUNOPATHOGENESIS OF RUBELLA VIRUS ASSOCIATED AUTOIMMUN
  • 批准号:
    6547798
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Hira L. Nakhasi
  • 依托单位:
    --
MOLECULAR MECHANISM OF MALARIA PATHOGENESIS: REGULATION OF TRANSCRIPTIONAL CONTRO
  • 批准号:
    6293684
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Hira L. Nakhasi
  • 依托单位:
    --